Peter Dempsey
Concepts (688)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| ADAM Proteins | 26 | 2015 | 63 | 2.830 |
Why?
| | Amyloid Precursor Protein Secretases | 13 | 2021 | 77 | 2.030 |
Why?
| | Intestines | 9 | 2026 | 358 | 1.830 |
Why?
| | Membrane Proteins | 20 | 2022 | 1166 | 1.560 |
Why?
| | Cell Plasticity | 3 | 2025 | 37 | 1.440 |
Why?
| | ADAM10 Protein | 15 | 2022 | 29 | 1.310 |
Why?
| | Stem Cell Niche | 3 | 2021 | 58 | 1.250 |
Why?
| | ErbB Receptors | 28 | 2018 | 627 | 1.230 |
Why?
| | Transforming Growth Factor alpha | 25 | 2013 | 56 | 1.220 |
Why?
| | Organoids | 11 | 2026 | 141 | 1.190 |
Why?
| | Intercellular Signaling Peptides and Proteins | 15 | 2013 | 381 | 1.180 |
Why?
| | Metalloendopeptidases | 14 | 2017 | 62 | 1.140 |
Why?
| | Intestinal Mucosa | 11 | 2026 | 676 | 1.110 |
Why?
| | Receptors, Notch | 3 | 2020 | 92 | 1.100 |
Why?
| | Protein Precursors | 8 | 2010 | 137 | 1.030 |
Why?
| | Breast Neoplasms | 27 | 2014 | 2452 | 0.960 |
Why?
| | Paneth Cells | 4 | 2026 | 20 | 0.930 |
Why?
| | Ultrasonography, Mammary | 8 | 2010 | 15 | 0.890 |
Why?
| | ADAM17 Protein | 19 | 2026 | 42 | 0.860 |
Why?
| | Integrases | 2 | 2018 | 122 | 0.840 |
Why?
| | Regeneration | 5 | 2026 | 197 | 0.810 |
Why?
| | Mammography | 17 | 2010 | 166 | 0.760 |
Why?
| | Breast | 11 | 2010 | 158 | 0.730 |
Why?
| | Biopsy, Needle | 8 | 2010 | 183 | 0.670 |
Why?
| | Intestinal Neoplasms | 2 | 2018 | 30 | 0.610 |
Why?
| | Pulmonary Embolism | 1 | 2022 | 244 | 0.590 |
Why?
| | alpha-Defensins | 1 | 2018 | 11 | 0.580 |
Why?
| | Parenteral Nutrition, Total | 2 | 2015 | 30 | 0.570 |
Why?
| | Signal Transduction | 26 | 2026 | 5226 | 0.560 |
Why?
| | Cell Membrane | 10 | 2017 | 706 | 0.550 |
Why?
| | Stem Cells | 4 | 2026 | 626 | 0.520 |
Why?
| | Epidermal Growth Factor | 13 | 2015 | 171 | 0.510 |
Why?
| | Proteolysis | 1 | 2017 | 173 | 0.490 |
Why?
| | Carcinogenesis | 2 | 2018 | 229 | 0.480 |
Why?
| | Mice | 49 | 2026 | 18339 | 0.480 |
Why?
| | Animals | 75 | 2026 | 38058 | 0.480 |
Why?
| | Breast Diseases | 4 | 2010 | 22 | 0.450 |
Why?
| | Growth Substances | 8 | 2001 | 140 | 0.440 |
Why?
| | Epithelial Cells | 12 | 2025 | 1125 | 0.430 |
Why?
| | Neuroendocrine Tumors | 1 | 2016 | 112 | 0.430 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2015 | 1217 | 0.400 |
Why?
| | Carcinoma, Lobular | 4 | 2014 | 56 | 0.400 |
Why?
| | Metalloproteases | 6 | 2017 | 42 | 0.390 |
Why?
| | Glycoproteins | 9 | 2008 | 355 | 0.390 |
Why?
| | Gastrointestinal Tract | 1 | 2015 | 208 | 0.380 |
Why?
| | Cell Dedifferentiation | 2 | 2026 | 32 | 0.380 |
Why?
| | Radiographic Image Enhancement | 3 | 2008 | 57 | 0.380 |
Why?
| | Cell Line | 20 | 2014 | 2882 | 0.370 |
Why?
| | Mice, Knockout | 14 | 2026 | 3121 | 0.360 |
Why?
| | Cell Proliferation | 11 | 2024 | 2496 | 0.360 |
Why?
| | Taste Buds | 2 | 2026 | 212 | 0.350 |
Why?
| | Protein Processing, Post-Translational | 8 | 2007 | 477 | 0.350 |
Why?
| | Radiology | 1 | 2014 | 174 | 0.350 |
Why?
| | Neoplasms | 6 | 2017 | 2875 | 0.340 |
Why?
| | Gene Targeting | 1 | 2010 | 82 | 0.320 |
Why?
| | Cell Lineage | 4 | 2026 | 376 | 0.310 |
Why?
| | Intestine, Small | 3 | 2025 | 166 | 0.310 |
Why?
| | Emergency Service, Hospital | 1 | 2022 | 2310 | 0.300 |
Why?
| | Unnecessary Procedures | 1 | 2010 | 53 | 0.300 |
Why?
| | Tamoxifen | 1 | 2010 | 217 | 0.300 |
Why?
| | Hydrogels | 4 | 2026 | 700 | 0.300 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2024 | 291 | 0.290 |
Why?
| | Cell Polarity | 6 | 2003 | 137 | 0.280 |
Why?
| | Cell Differentiation | 10 | 2026 | 2050 | 0.280 |
Why?
| | Mass Screening | 5 | 2009 | 1347 | 0.280 |
Why?
| | Radiographic Magnification | 1 | 2008 | 1 | 0.280 |
Why?
| | Stomach | 3 | 2009 | 109 | 0.270 |
Why?
| | Muscle, Smooth, Vascular | 7 | 2008 | 452 | 0.270 |
Why?
| | Thinness | 1 | 2008 | 99 | 0.270 |
Why?
| | Apoptosis | 10 | 2021 | 2430 | 0.270 |
Why?
| | Inflammation | 5 | 2019 | 2878 | 0.270 |
Why?
| | Terminology as Topic | 2 | 2007 | 255 | 0.260 |
Why?
| | Humans | 87 | 2026 | 144759 | 0.260 |
Why?
| | Peptide Fragments | 2 | 2010 | 699 | 0.250 |
Why?
| | Hyperplasia | 3 | 2018 | 174 | 0.240 |
Why?
| | Receptors, Interleukin-17 | 1 | 2026 | 6 | 0.240 |
Why?
| | Homeostasis | 2 | 2021 | 640 | 0.240 |
Why?
| | Phenylmercuric Acetate | 2 | 2008 | 2 | 0.240 |
Why?
| | Insulin-Secreting Cells | 1 | 2010 | 388 | 0.230 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2026 | 72 | 0.230 |
Why?
| | Transcriptional Activation | 6 | 2013 | 383 | 0.230 |
Why?
| | Amino Acid Sequence | 12 | 2017 | 2155 | 0.220 |
Why?
| | Mice, Inbred C57BL | 14 | 2026 | 5992 | 0.220 |
Why?
| | Drug Delivery Systems | 1 | 2008 | 380 | 0.210 |
Why?
| | Angiotensin II | 4 | 2008 | 97 | 0.210 |
Why?
| | Dogs | 8 | 2011 | 437 | 0.210 |
Why?
| | Pancreatic Neoplasms | 2 | 2024 | 919 | 0.210 |
Why?
| | Allyl Compounds | 2 | 2022 | 26 | 0.200 |
Why?
| | Protein Structure, Tertiary | 8 | 2010 | 862 | 0.200 |
Why?
| | Taste | 1 | 2026 | 239 | 0.200 |
Why?
| | beta Catenin | 2 | 2023 | 252 | 0.190 |
Why?
| | Sulfides | 2 | 2022 | 91 | 0.190 |
Why?
| | Molecular Sequence Data | 11 | 2011 | 2930 | 0.190 |
Why?
| | Betacellulin | 5 | 2010 | 6 | 0.180 |
Why?
| | Energy Metabolism | 1 | 2008 | 935 | 0.180 |
Why?
| | Mice, Transgenic | 11 | 2020 | 2182 | 0.180 |
Why?
| | Enzyme Inhibitors | 6 | 2008 | 824 | 0.180 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 122 | 0.170 |
Why?
| | Calcium | 5 | 2010 | 1183 | 0.170 |
Why?
| | Radiologists | 1 | 2022 | 60 | 0.170 |
Why?
| | Chest Pain | 1 | 2022 | 99 | 0.170 |
Why?
| | Gamma Rays | 1 | 2021 | 56 | 0.160 |
Why?
| | Ultrasonography | 8 | 2009 | 770 | 0.160 |
Why?
| | Microscopy | 1 | 2022 | 156 | 0.160 |
Why?
| | Immunohistochemistry | 6 | 2010 | 1716 | 0.160 |
Why?
| | Receptor, ErbB-4 | 3 | 2017 | 18 | 0.160 |
Why?
| | Cell Movement | 5 | 2021 | 965 | 0.160 |
Why?
| | Antibodies, Monoclonal | 8 | 2000 | 1519 | 0.160 |
Why?
| | Photolysis | 1 | 2020 | 94 | 0.150 |
Why?
| | Antiporters | 1 | 2019 | 22 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2026 | 969 | 0.150 |
Why?
| | Cell Survival | 2 | 2014 | 1098 | 0.150 |
Why?
| | Radiation Injuries | 1 | 2021 | 151 | 0.150 |
Why?
| | Gastric Mucosa | 7 | 2009 | 52 | 0.150 |
Why?
| | Colitis | 2 | 2019 | 280 | 0.150 |
Why?
| | Female | 40 | 2021 | 78271 | 0.150 |
Why?
| | Cells, Cultured | 17 | 2019 | 4154 | 0.150 |
Why?
| | Histones | 1 | 2025 | 669 | 0.150 |
Why?
| | History, 21st Century | 2 | 2014 | 219 | 0.150 |
Why?
| | Doxorubicin | 3 | 2018 | 397 | 0.150 |
Why?
| | Gene Deletion | 2 | 2018 | 389 | 0.150 |
Why?
| | T-Lymphocytes | 5 | 2013 | 1982 | 0.150 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2021 | 219 | 0.140 |
Why?
| | Adenomatous Polyposis Coli Protein | 1 | 2018 | 20 | 0.140 |
Why?
| | Multipotent Stem Cells | 1 | 2018 | 21 | 0.140 |
Why?
| | History, 20th Century | 2 | 2014 | 325 | 0.140 |
Why?
| | Acidosis | 1 | 2019 | 105 | 0.140 |
Why?
| | Colon | 3 | 2017 | 304 | 0.140 |
Why?
| | Protease Inhibitors | 4 | 2012 | 102 | 0.140 |
Why?
| | Fibrosis | 1 | 2021 | 548 | 0.140 |
Why?
| | Clone Cells | 1 | 2018 | 266 | 0.140 |
Why?
| | Mitosis | 2 | 2018 | 200 | 0.140 |
Why?
| | Sulfhydryl Compounds | 1 | 2020 | 189 | 0.140 |
Why?
| | Ligands | 8 | 2022 | 673 | 0.140 |
Why?
| | Atrophy | 2 | 2015 | 201 | 0.140 |
Why?
| | Leptin | 2 | 2010 | 245 | 0.130 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 73 | 0.130 |
Why?
| | EGF Family of Proteins | 7 | 2008 | 17 | 0.130 |
Why?
| | Adhesins, Bacterial | 1 | 2017 | 46 | 0.130 |
Why?
| | Amphiregulin | 7 | 2008 | 27 | 0.130 |
Why?
| | STAT3 Transcription Factor | 2 | 2018 | 207 | 0.130 |
Why?
| | Goblet Cells | 2 | 2014 | 22 | 0.130 |
Why?
| | Keratinocytes | 6 | 2010 | 248 | 0.130 |
Why?
| | Antineoplastic Agents | 2 | 2008 | 2194 | 0.130 |
Why?
| | Neutrophils | 3 | 2019 | 1134 | 0.120 |
Why?
| | Adenoma | 1 | 2018 | 218 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2013 | 668 | 0.120 |
Why?
| | Base Sequence | 6 | 2011 | 2190 | 0.120 |
Why?
| | Kidney | 5 | 2001 | 1495 | 0.120 |
Why?
| | Cytokines | 2 | 2015 | 2061 | 0.120 |
Why?
| | Gene Expression Regulation | 4 | 2014 | 2608 | 0.120 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2008 | 266 | 0.120 |
Why?
| | Endothelial Cells | 1 | 2022 | 869 | 0.120 |
Why?
| | X-Ray Intensifying Screens | 2 | 2006 | 3 | 0.120 |
Why?
| | Alleles | 1 | 2018 | 879 | 0.110 |
Why?
| | Sensitivity and Specificity | 5 | 2008 | 1985 | 0.110 |
Why?
| | Transfection | 7 | 2006 | 940 | 0.110 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 116 | 0.110 |
Why?
| | Receptor, Notch1 | 2 | 2013 | 64 | 0.110 |
Why?
| | Receptor, Notch2 | 2 | 2011 | 15 | 0.110 |
Why?
| | Time Factors | 6 | 2014 | 7173 | 0.110 |
Why?
| | Magnetic Resonance Imaging | 2 | 2009 | 3863 | 0.110 |
Why?
| | Amyloid beta-Protein Precursor | 2 | 2012 | 64 | 0.110 |
Why?
| | Hydrolysis | 5 | 2010 | 199 | 0.110 |
Why?
| | Enteroendocrine Cells | 1 | 2014 | 7 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 983 | 0.110 |
Why?
| | Kinetics | 5 | 2005 | 1627 | 0.110 |
Why?
| | Phenotype | 4 | 2014 | 3162 | 0.100 |
Why?
| | Lateral Ventricles | 1 | 2014 | 32 | 0.100 |
Why?
| | Solubility | 3 | 2020 | 242 | 0.100 |
Why?
| | B-Lymphocytes | 3 | 2010 | 876 | 0.100 |
Why?
| | Anesthesia, Local | 1 | 1993 | 25 | 0.100 |
Why?
| | Morphogenesis | 2 | 2026 | 173 | 0.100 |
Why?
| | Interleukin-6 | 1 | 2018 | 780 | 0.100 |
Why?
| | Neoplasm Staging | 5 | 2018 | 1462 | 0.100 |
Why?
| | ROC Curve | 4 | 2008 | 614 | 0.100 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1990 | 161 | 0.100 |
Why?
| | Cell Division | 8 | 2004 | 766 | 0.100 |
Why?
| | Immunoreceptor Tyrosine-Based Activation Motif | 1 | 2013 | 1 | 0.100 |
Why?
| | Gastritis, Hypertrophic | 1 | 1992 | 3 | 0.100 |
Why?
| | Tumor Cells, Cultured | 6 | 2021 | 919 | 0.100 |
Why?
| | Probiotics | 1 | 2013 | 61 | 0.100 |
Why?
| | Cell Nucleus | 3 | 2018 | 618 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2007 | 1489 | 0.100 |
Why?
| | Toll-Like Receptor 4 | 1 | 2015 | 276 | 0.090 |
Why?
| | Cell Line, Tumor | 6 | 2024 | 3540 | 0.090 |
Why?
| | Cadherins | 1 | 2014 | 201 | 0.090 |
Why?
| | Blotting, Western | 5 | 2008 | 1187 | 0.090 |
Why?
| | CD3 Complex | 1 | 2013 | 111 | 0.090 |
Why?
| | Protein Kinase C | 4 | 2003 | 252 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2014 | 166 | 0.090 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2017 | 365 | 0.090 |
Why?
| | Skin | 3 | 2010 | 755 | 0.090 |
Why?
| | Protein Kinase C-delta | 3 | 2008 | 46 | 0.090 |
Why?
| | Genes, ras | 3 | 1998 | 96 | 0.090 |
Why?
| | Reproducibility of Results | 5 | 2020 | 3409 | 0.090 |
Why?
| | Cytoplasm | 2 | 2003 | 269 | 0.090 |
Why?
| | Ultrasonography, Interventional | 3 | 2010 | 160 | 0.090 |
Why?
| | Biopsy, Fine-Needle | 2 | 2009 | 68 | 0.080 |
Why?
| | Macrophages | 2 | 2017 | 1511 | 0.080 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 299 | 0.080 |
Why?
| | Galactosides | 1 | 2010 | 9 | 0.080 |
Why?
| | Extracellular Matrix | 3 | 2022 | 553 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2020 | 459 | 0.080 |
Why?
| | Presenilin-2 | 1 | 2010 | 6 | 0.080 |
Why?
| | Protein Transport | 2 | 2003 | 441 | 0.080 |
Why?
| | Light | 2 | 2026 | 411 | 0.080 |
Why?
| | Estrogen Antagonists | 1 | 2010 | 48 | 0.080 |
Why?
| | Crosses, Genetic | 1 | 2010 | 124 | 0.080 |
Why?
| | Presenilin-1 | 1 | 2010 | 33 | 0.080 |
Why?
| | Lipoylation | 1 | 2010 | 17 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2022 | 17066 | 0.080 |
Why?
| | Male | 16 | 2026 | 72315 | 0.080 |
Why?
| | Recovery of Function | 1 | 2014 | 707 | 0.080 |
Why?
| | Receptors, IgE | 1 | 2010 | 43 | 0.080 |
Why?
| | TRPV Cation Channels | 1 | 2010 | 43 | 0.080 |
Why?
| | Hydrogen Peroxide | 3 | 2006 | 336 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2010 | 275 | 0.080 |
Why?
| | Hair | 1 | 2010 | 88 | 0.080 |
Why?
| | Peptides | 1 | 1995 | 995 | 0.080 |
Why?
| | Paclitaxel | 3 | 2024 | 255 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2024 | 928 | 0.070 |
Why?
| | Calcinosis | 2 | 2006 | 234 | 0.070 |
Why?
| | Radiography | 3 | 2014 | 844 | 0.070 |
Why?
| | DNA, Complementary | 3 | 2010 | 276 | 0.070 |
Why?
| | Laminin | 2 | 2025 | 72 | 0.070 |
Why?
| | Mutagenesis | 2 | 2001 | 192 | 0.070 |
Why?
| | Helicobacter Infections | 1 | 2009 | 30 | 0.070 |
Why?
| | Antigens, CD | 3 | 2007 | 555 | 0.070 |
Why?
| | Uncoupling Protein 1 | 1 | 2008 | 17 | 0.070 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2008 | 12 | 0.070 |
Why?
| | Fats | 1 | 2008 | 17 | 0.070 |
Why?
| | Immunoglobulin G | 2 | 2010 | 893 | 0.070 |
Why?
| | Lymphocyte Activation | 3 | 2013 | 1126 | 0.070 |
Why?
| | Disintegrins | 2 | 2007 | 6 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2018 | 1455 | 0.070 |
Why?
| | Hydroxamic Acids | 3 | 2006 | 94 | 0.070 |
Why?
| | Fluorescent Dyes | 1 | 2010 | 329 | 0.070 |
Why?
| | Adult | 16 | 2010 | 40449 | 0.070 |
Why?
| | Enzyme Precursors | 1 | 2007 | 15 | 0.070 |
Why?
| | Ion Channels | 1 | 2008 | 129 | 0.070 |
Why?
| | Isoenzymes | 2 | 2000 | 299 | 0.070 |
Why?
| | Swine | 1 | 2010 | 833 | 0.070 |
Why?
| | HEK293 Cells | 3 | 2017 | 744 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2007 | 37 | 0.070 |
Why?
| | Hypothalamus | 1 | 2008 | 153 | 0.070 |
Why?
| | Intercellular Junctions | 2 | 2000 | 35 | 0.070 |
Why?
| | Efficiency | 1 | 2008 | 103 | 0.070 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2006 | 233 | 0.060 |
Why?
| | Observer Variation | 1 | 2008 | 355 | 0.060 |
Why?
| | Receptors, Cell Surface | 3 | 2022 | 377 | 0.060 |
Why?
| | Ultrasonography, Doppler | 1 | 2007 | 126 | 0.060 |
Why?
| | Bacterial Proteins | 1 | 2013 | 955 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2000 | 339 | 0.060 |
Why?
| | Adipocytes | 1 | 2008 | 223 | 0.060 |
Why?
| | Middle Aged | 14 | 2007 | 35875 | 0.060 |
Why?
| | Heparin-binding EGF-like Growth Factor | 3 | 2013 | 16 | 0.060 |
Why?
| | Dysgeusia | 1 | 2026 | 5 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1953 | 0.060 |
Why?
| | Disease Models, Animal | 5 | 2019 | 4557 | 0.060 |
Why?
| | Phosphorylation | 6 | 2013 | 1732 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 3 | 2004 | 292 | 0.060 |
Why?
| | Mitochondrial Proteins | 1 | 2008 | 262 | 0.060 |
Why?
| | Receptor, ErbB-3 | 1 | 2006 | 48 | 0.060 |
Why?
| | Cell Line, Transformed | 2 | 2004 | 140 | 0.060 |
Why?
| | Tyrosine | 3 | 2008 | 222 | 0.060 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2008 | 285 | 0.060 |
Why?
| | Eating | 1 | 2008 | 389 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2004 | 851 | 0.060 |
Why?
| | Colorectal Neoplasms | 2 | 2018 | 845 | 0.060 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2005 | 8 | 0.060 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2006 | 121 | 0.060 |
Why?
| | Receptors, Progesterone | 1 | 2007 | 356 | 0.060 |
Why?
| | Early Detection of Cancer | 1 | 2010 | 463 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2010 | 1370 | 0.060 |
Why?
| | Interleukin-17 | 1 | 2026 | 118 | 0.060 |
Why?
| | Nucleoside-Phosphate Kinase | 1 | 2005 | 1 | 0.060 |
Why?
| | Neoplasm, Residual | 1 | 2006 | 139 | 0.060 |
Why?
| | United States | 3 | 2014 | 15966 | 0.060 |
Why?
| | Endothelin-1 | 1 | 2006 | 184 | 0.050 |
Why?
| | Colonic Neoplasms | 2 | 1999 | 259 | 0.050 |
Why?
| | Organ Culture Techniques | 3 | 2014 | 154 | 0.050 |
Why?
| | Rats | 9 | 2008 | 5597 | 0.050 |
Why?
| | Biological Transport | 3 | 2008 | 417 | 0.050 |
Why?
| | Ion Transport | 1 | 2004 | 63 | 0.050 |
Why?
| | GTP-Binding Proteins | 1 | 2005 | 153 | 0.050 |
Why?
| | Receptors, Estrogen | 1 | 2007 | 457 | 0.050 |
Why?
| | RNA, Messenger | 7 | 2018 | 2832 | 0.050 |
Why?
| | Gastric Acid | 2 | 1995 | 14 | 0.050 |
Why?
| | Physical Examination | 1 | 2006 | 239 | 0.050 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2006 | 421 | 0.050 |
Why?
| | Methylation | 1 | 2025 | 242 | 0.050 |
Why?
| | Mice, Nude | 2 | 2024 | 682 | 0.050 |
Why?
| | Chemokines, CXC | 1 | 2004 | 68 | 0.050 |
Why?
| | Enzyme Activation | 4 | 2013 | 766 | 0.050 |
Why?
| | Molecular Weight | 3 | 1997 | 327 | 0.050 |
Why?
| | Up-Regulation | 2 | 2019 | 851 | 0.050 |
Why?
| | Heparin | 1 | 2005 | 244 | 0.050 |
Why?
| | Motor Activity | 1 | 2008 | 721 | 0.050 |
Why?
| | DNA Primers | 1 | 2004 | 512 | 0.050 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2003 | 40 | 0.050 |
Why?
| | Leiomyosarcoma | 1 | 2003 | 28 | 0.050 |
Why?
| | Receptor Protein-Tyrosine Kinases | 2 | 2003 | 230 | 0.050 |
Why?
| | Neurons | 1 | 2012 | 1640 | 0.050 |
Why?
| | Mutation | 5 | 2010 | 4089 | 0.050 |
Why?
| | Mammary Glands, Animal | 2 | 1995 | 128 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2007 | 780 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 206 | 0.050 |
Why?
| | Deoxycytidine | 1 | 2024 | 221 | 0.050 |
Why?
| | Tongue | 1 | 2023 | 76 | 0.050 |
Why?
| | Amino Acid Motifs | 1 | 2003 | 224 | 0.050 |
Why?
| | Leucine | 1 | 2003 | 116 | 0.050 |
Why?
| | Uterine Neoplasms | 1 | 2003 | 96 | 0.050 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 2002 | 18 | 0.050 |
Why?
| | SOXB1 Transcription Factors | 1 | 2023 | 67 | 0.050 |
Why?
| | Cysts | 2 | 1992 | 111 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 2003 | 200 | 0.050 |
Why?
| | Epithelium | 3 | 1995 | 314 | 0.040 |
Why?
| | Gene Knockdown Techniques | 2 | 2013 | 336 | 0.040 |
Why?
| | Wnt Signaling Pathway | 1 | 2024 | 210 | 0.040 |
Why?
| | Dandy-Walker Syndrome | 1 | 1981 | 7 | 0.040 |
Why?
| | Chemokines, CX3C | 1 | 2001 | 10 | 0.040 |
Why?
| | Pyridines | 1 | 2026 | 605 | 0.040 |
Why?
| | Women's Health | 1 | 2004 | 310 | 0.040 |
Why?
| | Hedgehog Proteins | 1 | 2023 | 197 | 0.040 |
Why?
| | Milk Proteins | 2 | 1995 | 35 | 0.040 |
Why?
| | Polyethylene Glycols | 1 | 2026 | 654 | 0.040 |
Why?
| | Aged | 8 | 2007 | 25913 | 0.040 |
Why?
| | Ephrin-B2 | 1 | 2021 | 45 | 0.040 |
Why?
| | Prevalence | 1 | 2008 | 2834 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2001 | 193 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2005 | 737 | 0.040 |
Why?
| | Precipitin Tests | 3 | 2004 | 93 | 0.040 |
Why?
| | Prognosis | 2 | 2021 | 4282 | 0.040 |
Why?
| | Phenylalanine | 2 | 1998 | 71 | 0.040 |
Why?
| | Retroviridae Proteins, Oncogenic | 1 | 2000 | 10 | 0.040 |
Why?
| | Hydrocephalus | 1 | 1981 | 111 | 0.040 |
Why?
| | Quinazolines | 2 | 2015 | 266 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2022 | 286 | 0.040 |
Why?
| | Shear Strength | 1 | 2020 | 72 | 0.040 |
Why?
| | Brain Diseases | 1 | 1981 | 152 | 0.040 |
Why?
| | Thiophenes | 2 | 1998 | 128 | 0.040 |
Why?
| | Brain | 2 | 2010 | 2933 | 0.040 |
Why?
| | CD40 Antigens | 1 | 2000 | 90 | 0.040 |
Why?
| | Leukocyte Disorders | 1 | 2019 | 9 | 0.040 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2019 | 26 | 0.040 |
Why?
| | Rheology | 1 | 2020 | 94 | 0.040 |
Why?
| | Proteins | 3 | 2005 | 1021 | 0.040 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2019 | 30 | 0.040 |
Why?
| | Glycosylation | 2 | 1998 | 172 | 0.040 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2003 | 433 | 0.040 |
Why?
| | Prenatal Diagnosis | 1 | 1981 | 195 | 0.040 |
Why?
| | Carcinoma | 2 | 1995 | 228 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 623 | 0.040 |
Why?
| | Fetal Diseases | 1 | 1981 | 191 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2019 | 39 | 0.040 |
Why?
| | Neutrophil Activation | 1 | 2019 | 85 | 0.040 |
Why?
| | Autocrine Communication | 1 | 1999 | 38 | 0.040 |
Why?
| | Insulin | 1 | 2010 | 2507 | 0.040 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 1999 | 17 | 0.040 |
Why?
| | Fibroblasts | 2 | 2002 | 1034 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 436 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2020 | 219 | 0.040 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 45 | 0.040 |
Why?
| | Pain | 2 | 1993 | 779 | 0.040 |
Why?
| | Vanadates | 1 | 1998 | 17 | 0.040 |
Why?
| | Genes, p53 | 1 | 1998 | 67 | 0.040 |
Why?
| | Epitopes | 3 | 1990 | 485 | 0.030 |
Why?
| | Mucin-2 | 1 | 2017 | 2 | 0.030 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 1999 | 162 | 0.030 |
Why?
| | Glycosaminoglycans | 1 | 1998 | 74 | 0.030 |
Why?
| | Oligodeoxyribonucleotides | 1 | 1998 | 141 | 0.030 |
Why?
| | Adenosine | 1 | 2019 | 255 | 0.030 |
Why?
| | Cell Adhesion | 3 | 2014 | 455 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 2022 | 435 | 0.030 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2018 | 40 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2018 | 117 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2000 | 344 | 0.030 |
Why?
| | In Vitro Techniques | 3 | 2006 | 1047 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1996 | 193 | 0.030 |
Why?
| | Neutralization Tests | 3 | 1995 | 76 | 0.030 |
Why?
| | Receptor, Angiotensin, Type 1 | 2 | 2008 | 25 | 0.030 |
Why?
| | Dipeptides | 2 | 2008 | 57 | 0.030 |
Why?
| | Graft Rejection | 1 | 2000 | 540 | 0.030 |
Why?
| | Neuregulins | 1 | 2017 | 7 | 0.030 |
Why?
| | Aged, 80 and over | 3 | 2007 | 8265 | 0.030 |
Why?
| | Extracellular Space | 1 | 1997 | 120 | 0.030 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2017 | 75 | 0.030 |
Why?
| | Prostaglandin-Endoperoxide Synthases | 1 | 1997 | 74 | 0.030 |
Why?
| | Predictive Value of Tests | 3 | 2007 | 2115 | 0.030 |
Why?
| | Hypertrophy | 2 | 2008 | 127 | 0.030 |
Why?
| | Prostaglandins | 1 | 1997 | 94 | 0.030 |
Why?
| | Tumor Burden | 1 | 2018 | 319 | 0.030 |
Why?
| | Transcription, Genetic | 4 | 2000 | 1496 | 0.030 |
Why?
| | Spleen | 2 | 2010 | 508 | 0.030 |
Why?
| | Models, Biological | 2 | 2020 | 1821 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 5868 | 0.030 |
Why?
| | Foreign Bodies | 1 | 1997 | 107 | 0.030 |
Why?
| | COS Cells | 2 | 2007 | 181 | 0.030 |
Why?
| | Mice, Inbred DBA | 2 | 1994 | 187 | 0.030 |
Why?
| | CHO Cells | 2 | 2007 | 171 | 0.030 |
Why?
| | Survival Rate | 1 | 2021 | 2089 | 0.030 |
Why?
| | Neoplasm Invasiveness | 2 | 2007 | 508 | 0.030 |
Why?
| | Cricetinae | 2 | 2007 | 303 | 0.030 |
Why?
| | Uterus | 1 | 1977 | 226 | 0.030 |
Why?
| | Catheterization, Central Venous | 1 | 1997 | 122 | 0.030 |
Why?
| | Cyclophosphamide | 2 | 2006 | 266 | 0.030 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 570 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 688 | 0.030 |
Why?
| | Transforming Growth Factor beta | 2 | 1995 | 479 | 0.030 |
Why?
| | Immunoblotting | 2 | 2008 | 300 | 0.030 |
Why?
| | Fluorouracil | 2 | 2006 | 235 | 0.030 |
Why?
| | Repressor Proteins | 1 | 1998 | 437 | 0.030 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 6048 | 0.030 |
Why?
| | Caco-2 Cells | 3 | 1999 | 79 | 0.030 |
Why?
| | Genes, Dominant | 2 | 2006 | 101 | 0.030 |
Why?
| | Receptors, Growth Factor | 1 | 1994 | 56 | 0.030 |
Why?
| | Cerebral Angiography | 1 | 1975 | 119 | 0.030 |
Why?
| | Wiskott-Aldrich Syndrome Protein Family | 1 | 2014 | 3 | 0.030 |
Why?
| | 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase | 1 | 2014 | 5 | 0.030 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 1994 | 69 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 4 | 2003 | 2527 | 0.030 |
Why?
| | Myelin Proteins | 1 | 2014 | 45 | 0.030 |
Why?
| | Biopsy, Large-Core Needle | 1 | 2014 | 15 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2000 | 1129 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2000 | 736 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 2014 | 44 | 0.030 |
Why?
| | Demyelinating Diseases | 1 | 2014 | 84 | 0.030 |
Why?
| | Proteoglycans | 1 | 2014 | 110 | 0.030 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1994 | 70 | 0.030 |
Why?
| | Age Factors | 3 | 2009 | 3333 | 0.030 |
Why?
| | Gene Expression | 2 | 1998 | 1490 | 0.030 |
Why?
| | Liver Regeneration | 1 | 1993 | 46 | 0.020 |
Why?
| | Mitogens | 1 | 1993 | 55 | 0.020 |
Why?
| | Lidocaine | 1 | 1993 | 54 | 0.020 |
Why?
| | Injections, Subcutaneous | 1 | 1993 | 164 | 0.020 |
Why?
| | Fibroblast Growth Factors | 1 | 1994 | 188 | 0.020 |
Why?
| | Adenoviridae | 2 | 2005 | 199 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 1994 | 540 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2013 | 2 | 0.020 |
Why?
| | Radiology, Interventional | 1 | 1993 | 49 | 0.020 |
Why?
| | Metallothionein | 1 | 1992 | 25 | 0.020 |
Why?
| | Stomach Diseases | 1 | 1992 | 20 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2012 | 32 | 0.020 |
Why?
| | Menstrual Cycle | 1 | 1993 | 140 | 0.020 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 2003 | 153 | 0.020 |
Why?
| | Antigens | 1 | 2014 | 347 | 0.020 |
Why?
| | Keratins | 1 | 1993 | 172 | 0.020 |
Why?
| | Risk Factors | 4 | 2010 | 10779 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 269 | 0.020 |
Why?
| | Mammary Tumor Virus, Mouse | 1 | 1992 | 45 | 0.020 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1054 | 0.020 |
Why?
| | Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2011 | 6 | 0.020 |
Why?
| | Retroviridae | 2 | 2005 | 101 | 0.020 |
Why?
| | Contrast Media | 1 | 1975 | 488 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2013 | 167 | 0.020 |
Why?
| | Pregnancy Complications | 1 | 1977 | 592 | 0.020 |
Why?
| | Preoperative Care | 1 | 1993 | 379 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 128 | 0.020 |
Why?
| | Genes, BRCA2 | 1 | 2010 | 33 | 0.020 |
Why?
| | Genes, BRCA1 | 1 | 2010 | 45 | 0.020 |
Why?
| | Hybridomas | 1 | 1990 | 234 | 0.020 |
Why?
| | Antibody Specificity | 1 | 1990 | 181 | 0.020 |
Why?
| | Colony-Stimulating Factors | 1 | 1990 | 37 | 0.020 |
Why?
| | Receptors, CCR1 | 1 | 2010 | 4 | 0.020 |
Why?
| | Pregnancy | 3 | 1995 | 7190 | 0.020 |
Why?
| | Homeodomain Proteins | 2 | 2007 | 523 | 0.020 |
Why?
| | Preoperative Period | 1 | 2010 | 149 | 0.020 |
Why?
| | Body Fluids | 1 | 2010 | 70 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 143 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2005 | 427 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 771 | 0.020 |
Why?
| | SEER Program | 1 | 2010 | 224 | 0.020 |
Why?
| | Gene Amplification | 1 | 2010 | 120 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 1990 | 320 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 331 | 0.020 |
Why?
| | Bone Marrow | 1 | 1990 | 304 | 0.020 |
Why?
| | Elective Surgical Procedures | 1 | 2010 | 201 | 0.020 |
Why?
| | Cerebral Cortex | 1 | 2012 | 464 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2009 | 54 | 0.020 |
Why?
| | Alabama | 1 | 1988 | 33 | 0.020 |
Why?
| | Recombination, Genetic | 1 | 2010 | 205 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2010 | 178 | 0.020 |
Why?
| | Helicobacter pylori | 1 | 2009 | 45 | 0.020 |
Why?
| | Exons | 1 | 2010 | 358 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2000 | 396 | 0.020 |
Why?
| | Tyrphostins | 1 | 2008 | 18 | 0.020 |
Why?
| | DNA | 4 | 1999 | 1463 | 0.020 |
Why?
| | Tissue Array Analysis | 1 | 2008 | 50 | 0.020 |
Why?
| | Intracellular Membranes | 1 | 2008 | 76 | 0.020 |
Why?
| | Caspase 3 | 1 | 2009 | 238 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2008 | 19 | 0.020 |
Why?
| | Exocytosis | 1 | 2008 | 84 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 1995 | 847 | 0.020 |
Why?
| | Axilla | 1 | 2007 | 51 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 240 | 0.020 |
Why?
| | Mice, Inbred BALB C | 3 | 1995 | 1253 | 0.020 |
Why?
| | src-Family Kinases | 1 | 2008 | 93 | 0.020 |
Why?
| | Proteomics | 1 | 2014 | 1195 | 0.020 |
Why?
| | Premenopause | 1 | 2007 | 123 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2011 | 1257 | 0.020 |
Why?
| | Calcimycin | 1 | 2006 | 36 | 0.020 |
Why?
| | Cricetulus | 1 | 2007 | 118 | 0.020 |
Why?
| | Fibronectins | 1 | 1987 | 136 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 1994 | 928 | 0.020 |
Why?
| | Fixatives | 1 | 1986 | 13 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2008 | 402 | 0.020 |
Why?
| | Growth and Development | 1 | 2006 | 9 | 0.020 |
Why?
| | Histocytochemistry | 1 | 1986 | 79 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 117 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 333 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2006 | 128 | 0.010 |
Why?
| | Artifacts | 1 | 2006 | 139 | 0.010 |
Why?
| | Antigens, Surface | 1 | 1986 | 157 | 0.010 |
Why?
| | Binding Sites | 2 | 2005 | 1329 | 0.010 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 294 | 0.010 |
Why?
| | Organ Specificity | 1 | 1986 | 312 | 0.010 |
Why?
| | Ionophores | 1 | 2005 | 21 | 0.010 |
Why?
| | Phantoms, Imaging | 1 | 2006 | 158 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2006 | 151 | 0.010 |
Why?
| | Lac Operon | 1 | 2005 | 44 | 0.010 |
Why?
| | Rabbits | 1 | 2006 | 648 | 0.010 |
Why?
| | Guanylate Kinases | 1 | 2005 | 13 | 0.010 |
Why?
| | Type C Phospholipases | 1 | 2005 | 69 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2005 | 59 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2003 | 2027 | 0.010 |
Why?
| | Specimen Handling | 1 | 2006 | 186 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2006 | 427 | 0.010 |
Why?
| | Aorta | 1 | 2008 | 429 | 0.010 |
Why?
| | Liver | 1 | 1993 | 1887 | 0.010 |
Why?
| | Guinea Pigs | 2 | 1996 | 159 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2005 | 145 | 0.010 |
Why?
| | Chemokine CXCL6 | 1 | 2004 | 2 | 0.010 |
Why?
| | Chemokine CXCL16 | 1 | 2004 | 4 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5408 | 0.010 |
Why?
| | Receptors, Scavenger | 1 | 2004 | 22 | 0.010 |
Why?
| | Culture Media, Conditioned | 2 | 1995 | 111 | 0.010 |
Why?
| | Macrophages, Peritoneal | 1 | 2004 | 89 | 0.010 |
Why?
| | Cytodiagnosis | 1 | 2003 | 31 | 0.010 |
Why?
| | Acetophenones | 1 | 2003 | 13 | 0.010 |
Why?
| | Janus Kinase 2 | 1 | 2003 | 29 | 0.010 |
Why?
| | RNA | 1 | 2010 | 940 | 0.010 |
Why?
| | Benzopyrans | 1 | 2003 | 30 | 0.010 |
Why?
| | Catalysis | 1 | 2004 | 322 | 0.010 |
Why?
| | Radioimmunoassay | 2 | 1993 | 165 | 0.010 |
Why?
| | Hematopoietic Stem Cells | 1 | 1986 | 420 | 0.010 |
Why?
| | Neoadjuvant Therapy | 1 | 2006 | 462 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 337 | 0.010 |
Why?
| | Reactive Oxygen Species | 1 | 2005 | 621 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 675 | 0.010 |
Why?
| | Cranial Fossa, Posterior | 1 | 1981 | 20 | 0.010 |
Why?
| | Chemokine CX3CL1 | 1 | 2001 | 25 | 0.010 |
Why?
| | Fetus | 1 | 1986 | 803 | 0.010 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 635 | 0.010 |
Why?
| | B7-2 Antigen | 1 | 2000 | 27 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 48 | 0.010 |
Why?
| | Immune Sera | 1 | 2000 | 77 | 0.010 |
Why?
| | Antibodies, Blocking | 1 | 2000 | 37 | 0.010 |
Why?
| | CD28 Antigens | 1 | 2000 | 58 | 0.010 |
Why?
| | B7-1 Antigen | 1 | 2000 | 55 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 2000 | 116 | 0.010 |
Why?
| | CD40 Ligand | 1 | 2000 | 40 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 2000 | 121 | 0.010 |
Why?
| | Lymphopenia | 1 | 2000 | 65 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2000 | 200 | 0.010 |
Why?
| | Receptor Cross-Talk | 1 | 2000 | 21 | 0.010 |
Why?
| | Oncogene Protein v-crk | 1 | 2000 | 1 | 0.010 |
Why?
| | Retinoblastoma-Like Protein p130 | 1 | 2000 | 3 | 0.010 |
Why?
| | Genes, src | 1 | 2000 | 5 | 0.010 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 153 | 0.010 |
Why?
| | Crk-Associated Substrate Protein | 1 | 2000 | 4 | 0.010 |
Why?
| | src Homology Domains | 1 | 2000 | 35 | 0.010 |
Why?
| | Retinoblastoma Protein | 1 | 2000 | 61 | 0.010 |
Why?
| | Costs and Cost Analysis | 1 | 2001 | 219 | 0.010 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 266 | 0.010 |
Why?
| | Transplantation, Homologous | 1 | 2000 | 415 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2000 | 156 | 0.010 |
Why?
| | Epidermis | 1 | 2000 | 157 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2000 | 366 | 0.010 |
Why?
| | Cytochrome P-450 Enzyme Inhibitors | 1 | 1999 | 13 | 0.010 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2000 | 202 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1782 | 0.010 |
Why?
| | Drug Resistance, Multiple | 1 | 1999 | 25 | 0.010 |
Why?
| | Pharmacokinetics | 1 | 1999 | 32 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 2003 | 1087 | 0.010 |
Why?
| | Carcinogenicity Tests | 1 | 1998 | 10 | 0.010 |
Why?
| | CCN Intercellular Signaling Proteins | 1 | 1998 | 5 | 0.010 |
Why?
| | Ribonucleases | 1 | 1999 | 49 | 0.010 |
Why?
| | Thiocarbamates | 1 | 1998 | 6 | 0.010 |
Why?
| | Protein Binding | 1 | 2005 | 2273 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 1998 | 74 | 0.010 |
Why?
| | Genes, Viral | 1 | 1998 | 90 | 0.010 |
Why?
| | Rodentia | 1 | 1998 | 61 | 0.010 |
Why?
| | Arsenicals | 1 | 1998 | 28 | 0.010 |
Why?
| | Cytochrome P-450 CYP3A | 1 | 1999 | 93 | 0.010 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 1999 | 88 | 0.010 |
Why?
| | Coronary Disease | 1 | 2000 | 383 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1999 | 388 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2000 | 496 | 0.010 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 594 | 0.010 |
Why?
| | Surface Properties | 1 | 1999 | 410 | 0.010 |
Why?
| | Pyrrolidines | 1 | 1998 | 125 | 0.010 |
Why?
| | Polyethylene Terephthalates | 1 | 1997 | 21 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2001 | 1173 | 0.010 |
Why?
| | Pregnancy, Multiple | 1 | 1977 | 18 | 0.010 |
Why?
| | Polyhydramnios | 1 | 1977 | 17 | 0.010 |
Why?
| | Foreign-Body Reaction | 1 | 1997 | 36 | 0.010 |
Why?
| | Nitrobenzenes | 1 | 1997 | 17 | 0.010 |
Why?
| | DNA Replication | 1 | 1999 | 251 | 0.010 |
Why?
| | Sulindac | 1 | 1997 | 16 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1998 | 167 | 0.010 |
Why?
| | Cyclooxygenase 2 Inhibitors | 1 | 1997 | 23 | 0.010 |
Why?
| | Catheters, Indwelling | 1 | 1997 | 96 | 0.010 |
Why?
| | Cell Compartmentation | 1 | 1997 | 54 | 0.010 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 81 | 0.010 |
Why?
| | RNA, Neoplasm | 1 | 1997 | 86 | 0.010 |
Why?
| | Cyclooxygenase 2 | 1 | 1997 | 165 | 0.010 |
Why?
| | Pyelonephritis | 1 | 1975 | 11 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1975 | 8 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1996 | 327 | 0.010 |
Why?
| | Aging | 2 | 1998 | 1966 | 0.010 |
Why?
| | Diatrizoate | 1 | 1975 | 2 | 0.010 |
Why?
| | Cell Cycle | 1 | 1998 | 596 | 0.010 |
Why?
| | Caseins | 1 | 1995 | 20 | 0.010 |
Why?
| | Iothalamic Acid | 1 | 1975 | 5 | 0.010 |
Why?
| | Subtraction Technique | 1 | 1975 | 26 | 0.010 |
Why?
| | Adolescent | 2 | 2010 | 22428 | 0.010 |
Why?
| | Papilloma | 1 | 1995 | 49 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1994 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 1 | 1 | 1994 | 13 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1994 | 23 | 0.010 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1994 | 28 | 0.010 |
Why?
| | Blotting, Northern | 1 | 1994 | 204 | 0.010 |
Why?
| | Integrins | 1 | 1995 | 89 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1996 | 561 | 0.010 |
Why?
| | Drosophila | 1 | 1996 | 166 | 0.010 |
Why?
| | Chronic Disease | 1 | 2000 | 1813 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 1994 | 25 | 0.010 |
Why?
| | Fibroblast Growth Factor 2 | 1 | 1994 | 93 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 1995 | 130 | 0.010 |
Why?
| | Head | 1 | 1975 | 120 | 0.010 |
Why?
| | Lactation | 1 | 1995 | 192 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1993 | 12 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1975 | 207 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1993 | 37 | 0.010 |
Why?
| | Culture Media, Serum-Free | 1 | 1993 | 42 | 0.010 |
Why?
| | Thymidine | 1 | 1993 | 60 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1993 | 131 | 0.010 |
Why?
| | Osmolar Concentration | 1 | 1993 | 167 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2000 | 1499 | 0.010 |
Why?
| | Biological Factors | 1 | 1993 | 39 | 0.010 |
Why?
| | Pyrazoles | 1 | 1997 | 509 | 0.010 |
Why?
| | Movement | 1 | 1975 | 293 | 0.010 |
Why?
| | Sulfonamides | 1 | 1997 | 580 | 0.010 |
Why?
| | Cell Count | 1 | 1993 | 320 | 0.010 |
Why?
| | Gastric Juice | 1 | 1992 | 6 | 0.010 |
Why?
| | Hydrochloric Acid | 1 | 1992 | 9 | 0.010 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1992 | 28 | 0.010 |
Why?
| | Insulin-Like Growth Factor I | 1 | 1994 | 319 | 0.010 |
Why?
| | Isoquinolines | 1 | 1992 | 44 | 0.010 |
Why?
| | Rats, Inbred Strains | 1 | 1992 | 321 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1994 | 902 | 0.010 |
Why?
| | Nucleic Acid Hybridization | 1 | 1992 | 187 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1992 | 415 | 0.010 |
Why?
| | Hepatectomy | 1 | 1993 | 273 | 0.010 |
Why?
| | Child | 1 | 2010 | 22633 | 0.010 |
Why?
| | Phytohemagglutinins | 1 | 1990 | 29 | 0.000 |
Why?
| | Receptors, Colony-Stimulating Factor | 1 | 1990 | 7 | 0.000 |
Why?
| | Colony-Forming Units Assay | 1 | 1990 | 95 | 0.000 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 85 | 0.000 |
Why?
| | Trypsin | 1 | 1990 | 76 | 0.000 |
Why?
| | Endopeptidases | 1 | 1990 | 82 | 0.000 |
Why?
| | Culture Media | 1 | 1990 | 161 | 0.000 |
Why?
| | Disulfides | 1 | 1990 | 96 | 0.000 |
Why?
| | Piperazines | 1 | 1992 | 381 | 0.000 |
Why?
| | Biological Assay | 1 | 1990 | 128 | 0.000 |
Why?
| | Superoxides | 1 | 1990 | 204 | 0.000 |
Why?
| | Adenine Nucleotides | 1 | 1968 | 21 | 0.000 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 1968 | 56 | 0.000 |
Why?
| | Myocardium | 1 | 1968 | 939 | 0.000 |
Why?
| | Renal Artery | 1 | 1975 | 43 | 0.000 |
Why?
| | Biopsy | 1 | 1975 | 1075 | 0.000 |
Why?
| | Tritium | 1 | 1968 | 68 | 0.000 |
Why?
| | Denervation | 1 | 1968 | 27 | 0.000 |
Why?
| | Adenylyl Cyclases | 1 | 1968 | 60 | 0.000 |
Why?
| | Cats | 1 | 1968 | 228 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1968 | 209 | 0.000 |
Why?
|
|
Dempsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|